ZA201700491B - Crystal of azole benzene derivative - Google Patents

Crystal of azole benzene derivative

Info

Publication number: ZA201700491B
Authority: ZA; South Africa
Prior art keywords: crystal; benzene derivative; azole benzene; azole; derivative
Prior art date: 2014-07-30

Application number

ZA2017/00491A

Inventor

Yuki Miyazawa

Asahi Kawana

Original Assignee

Teijin Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-07-30

Filing date

2017-01-20

Publication date

2018-04-25

2017-01-20 Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd

2018-04-25 Publication of ZA201700491B publication Critical patent/ZA201700491B/en

Links

REEJOFMTJPOBAY-UHFFFAOYSA-N benzene;1h-pyrrole Chemical class C=1C=CNC=1.C1=CC=CC=C1 REEJOFMTJPOBAY-UHFFFAOYSA-N 0.000 title 1
239000013078 crystal Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

ZA2017/00491A 2014-07-30 2017-01-20 Crystal of azole benzene derivative ZA201700491B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2014155031		2014-07-30
PCT/JP2015/071512 WO2016017696A1 (en)	2014-07-30	2015-07-29	Crystal of azole benzene derivative

Publications (1)

Publication Number	Publication Date
ZA201700491B true ZA201700491B (en)	2018-04-25

Family

ID=55217594

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA2017/00491A ZA201700491B (en)	2014-07-30	2017-01-20	Crystal of azole benzene derivative

Country Status (31)

Country	Link
US (1)	US9815826B2 (en)
EP (1)	EP3176165B1 (en)
JP (1)	JP6230713B2 (en)
KR (1)	KR20170033321A (en)
CN (1)	CN106536519B (en)
AR (1)	AR101363A1 (en)
AU (1)	AU2015297489B2 (en)
BR (1)	BR112017001659A2 (en)
CA (1)	CA2955485A1 (en)
CY (1)	CY1120933T1 (en)
DK (1)	DK3176165T3 (en)
ES (1)	ES2693382T3 (en)
HR (1)	HRP20181789T1 (en)
IL (1)	IL250144B (en)
LT (1)	LT3176165T (en)
MX (1)	MX370375B (en)
MY (1)	MY179339A (en)
NZ (1)	NZ729045A (en)
PH (1)	PH12017500123B1 (en)
PL (1)	PL3176165T3 (en)
PT (1)	PT3176165T (en)
RS (1)	RS57797B1 (en)
RU (1)	RU2675854C2 (en)
SA (1)	SA517380786B1 (en)
SG (1)	SG11201700742UA (en)
SI (1)	SI3176165T1 (en)
SM (1)	SMT201800646T1 (en)
TR (1)	TR201818775T4 (en)
TW (1)	TWI687418B (en)
WO (1)	WO2016017696A1 (en)
ZA (1)	ZA201700491B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2955577A1 (en) *	2014-07-30	2016-02-04	Teijin Pharma Limited	Xanthine oxidase inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2092580T3 (en)	1990-11-30	1996-12-01	Teijin Ltd	DERIVATIVE OF 2-ARYLTIAZOLE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME.
DE69632854T2 (en) *	1995-04-07	2005-07-14	Teijin Ltd.	Protective agent for organs and tissues
JP2002105067A (en)	2000-09-28	2002-04-10	Teijin Ltd	2-phenylthiazole derivative, and pharmaceutical composition containing the same as an active ingredient
AU2003290779A1 (en) *	2002-11-14	2004-06-03	Celmed Oncology (Usa), Inc.	Peptide deformylase activated prodrugs
JP5222561B2 (en) *	2005-10-07	2013-06-26	キッセイ薬品工業株式会社	Nitrogen-containing aromatic heterocyclic compound and pharmaceutical composition containing the same
WO2008126770A1 (en) *	2007-04-05	2008-10-23	Astellas Pharma Inc.	Method for producing triarylcarboxylic acid derivative
MX2009010491A (en)	2007-04-11	2009-11-09	Kissei Pharmaceutical	5-membered heterocyclic derivative and use thereof for medical purposes.
WO2010018458A2 (en)	2008-08-12	2010-02-18	Crystalgenomics, Inc.	Phenol derivatives and methods of use thereof
WO2010128163A2 (en)	2009-05-08	2010-11-11	Pike Pharma Gmbh	Small molecule inhibitors of influenza a and b virus and respiratory syncytial virus replication
EP2536699A2 (en) *	2010-02-19	2012-12-26	Cadila Healthcare Limited	Substantially pure salts of febuxostat and processes for preparation thereof
EP2563768A4 (en)	2010-04-29	2013-07-31	Reddys Lab Ltd Dr	Preparation of febuxostat
TWI606048B (en) *	2013-01-31	2017-11-21	帝人製藥股份有限公司	Oxazole derivatives

2015
- 2015-07-29 PL PL15827012T patent/PL3176165T3/en unknown
- 2015-07-29 DK DK15827012.4T patent/DK3176165T3/en active
- 2015-07-29 US US15/328,146 patent/US9815826B2/en not_active Expired - Fee Related
- 2015-07-29 RU RU2017106058A patent/RU2675854C2/en active
- 2015-07-29 WO PCT/JP2015/071512 patent/WO2016017696A1/en not_active Ceased
- 2015-07-29 RS RS20181280A patent/RS57797B1/en unknown
- 2015-07-29 CN CN201580040558.5A patent/CN106536519B/en not_active Expired - Fee Related
- 2015-07-29 BR BR112017001659-1A patent/BR112017001659A2/en active Search and Examination
- 2015-07-29 PT PT15827012T patent/PT3176165T/en unknown
- 2015-07-29 SG SG11201700742UA patent/SG11201700742UA/en unknown
- 2015-07-29 EP EP15827012.4A patent/EP3176165B1/en active Active
- 2015-07-29 LT LTEP15827012.4T patent/LT3176165T/en unknown
- 2015-07-29 JP JP2016538400A patent/JP6230713B2/en not_active Expired - Fee Related
- 2015-07-29 TW TW104124555A patent/TWI687418B/en not_active IP Right Cessation
- 2015-07-29 AU AU2015297489A patent/AU2015297489B2/en not_active Ceased
- 2015-07-29 CA CA2955485A patent/CA2955485A1/en not_active Abandoned
- 2015-07-29 MY MYPI2017700292A patent/MY179339A/en unknown
- 2015-07-29 SI SI201530420T patent/SI3176165T1/en unknown
- 2015-07-29 KR KR1020177002444A patent/KR20170033321A/en not_active Ceased
- 2015-07-29 NZ NZ729045A patent/NZ729045A/en unknown
- 2015-07-29 AR ARP150102422A patent/AR101363A1/en unknown
- 2015-07-29 SM SM20180646T patent/SMT201800646T1/en unknown
- 2015-07-29 MX MX2017000513A patent/MX370375B/en active IP Right Grant
- 2015-07-29 HR HRP20181789TT patent/HRP20181789T1/en unknown
- 2015-07-29 TR TR2018/18775T patent/TR201818775T4/en unknown
- 2015-07-29 ES ES15827012.4T patent/ES2693382T3/en active Active
2017
- 2017-01-16 IL IL25014417A patent/IL250144B/en active IP Right Grant
- 2017-01-20 ZA ZA2017/00491A patent/ZA201700491B/en unknown
- 2017-01-20 PH PH12017500123A patent/PH12017500123B1/en unknown
- 2017-01-24 SA SA517380786A patent/SA517380786B1/en unknown
2018
- 2018-11-29 CY CY181101270T patent/CY1120933T1/en unknown

Also Published As

Publication number	Publication date
MX370375B (en)	2019-12-11
EP3176165A4 (en)	2017-06-07
IL250144B (en)	2019-11-28
HRP20181789T1 (en)	2018-12-28
SI3176165T1 (en)	2018-11-30
RU2017106058A3 (en)	2018-08-28
US9815826B2 (en)	2017-11-14
SA517380786B1 (en)	2021-01-17
TW201619153A (en)	2016-06-01
RS57797B1 (en)	2018-12-31
DK3176165T3 (en)	2019-01-02
AR101363A1 (en)	2016-12-14
NZ729045A (en)	2022-05-27
US20170210735A1 (en)	2017-07-27
MX2017000513A (en)	2017-04-27
TR201818775T4 (en)	2019-01-21
MY179339A (en)	2020-11-04
CA2955485A1 (en)	2016-02-04
SG11201700742UA (en)	2017-03-30
CN106536519A (en)	2017-03-22
AU2015297489B2 (en)	2019-09-19
WO2016017696A1 (en)	2016-02-04
ES2693382T3 (en)	2018-12-11
PH12017500123A1 (en)	2017-05-29
LT3176165T (en)	2018-11-26
AU2015297489A1 (en)	2017-03-09
EP3176165B1 (en)	2018-09-26
EP3176165A1 (en)	2017-06-07
RU2675854C2 (en)	2018-12-25
PT3176165T (en)	2019-01-10
CY1120933T1 (en)	2019-12-11
BR112017001659A2 (en)	2018-01-30
JP6230713B2 (en)	2017-11-15
PL3176165T3 (en)	2019-03-29
CN106536519B (en)	2019-03-29
RU2017106058A (en)	2018-08-28
PH12017500123B1 (en)	2021-01-20
IL250144A0 (en)	2017-03-30
KR20170033321A (en)	2017-03-24
JPWO2016017696A1 (en)	2017-04-27
TWI687418B (en)	2020-03-11
SMT201800646T1 (en)	2019-01-11

Publication	Publication Date	Title
IL249345A0 (en)	2017-02-28	Ubstituted indazole compounds as irak4 inhibitors
EP3102576B8 (en)	2019-06-19	Dihydropyrrolopyridine inhibitors of ror-gamma
IL251584B (en)	2020-07-30	Dihydropyrrolopyridine inhibitors of ror-gamma
IL246555A0 (en)	2016-08-31	Indazole compounds as irak4 inhibitors
EP3125895A4 (en)	2017-08-30	Substituted spirocydic inhibitors of autotaxin
DK3209673T3 (en)	2020-11-02	Mixtures of HMOs
EP3110819A4 (en)	2017-08-02	Heterocyclic compounds
IL251777A0 (en)	2017-06-29	New pyrazole derivatives as nik inhibitors
EP3241822A4 (en)	2018-08-22	Urat1 inhibitor
PT3395819T (en)	2023-07-05	Crystal form of substituted aminopyran derivative
ZA201700491B (en)	2018-04-25	Crystal of azole benzene derivative
IL250143A0 (en)	2017-03-30	Azole benzene derivative and crystal thereof
HK1233952A1 (en)	2018-02-09	Substituted spirocydic inhibitors of autotaxin